Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID‐19): U.S. Multicenter Experience

Atoosa Rabiee, Brett Sadowski, Nia Adeniji, Ponni V. Perumalswami, Veronica Nguyen, Akshata Moghe, Nyan L. Latt, Sonal Kumar, Costica Aloman, Andreea M. Catana, Patricia P. Bloom, Kenneth D. Chavin, Rotonya M. Carr, Winston Dunn, Vincent L. Chen, Elizabeth S. Aby, Jose D. Debes, Renumathy Dhanasekaran, the COLD Consortium – 22 September 2020

Consequences of Extended Spectrum Beta‐Lactamase–Producing Enterobacteriaceae and Methicillin‐Resistant Staphylococcus aureus Carriage in Awaiting Liver Transplant Patients

Bianca Magro, Alessandra Mazzola, Mona Munteanu, Claire Goumard, Valerie Martinez, Denis Bernard, Olivier Scatton, Salvatore Battaglia, Ciro Celsa, Calogero Cammà, Filomena Conti – 21 September 2020 – Infections in patients with cirrhosis are associated with liver‐related complications (LRCs), especially in patients awaiting liver transplantation (LT). The aim of this study was to evaluate the impact of methicillin‐resistant Staphylococcus aureus (MRSA) and extended spectrum beta‐lactamase colonization on infections and LRCs for patients on the wait list and on infections after LT.

LiverLearning®: 2020 Webinar: Current and Future Disease Burden of HBV: Global and Regional Perspectives

In this on-demand webinar, representative speakers from Africa including North and Sub-Saharan Africa (Mark W. Sonderup, South Africa), East Asia (Jidong Jia, China), West and South Asia (Shiv K. Sarin, India), Europe including Western and Eastern Europe (George V. Papatheodoridis, Greece), North America (Carla Coffin, Canada) and South/Central America (Adrian Gadano) will each talk on HBV disease burden and primary challenges in their respective regions. They will present the current status and predictions for the next decade.

Subscribe to